Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Today Sponge

This article was originally published in The Tan Sheet

Executive Summary

Allendale Pharmaceuticals expects an ad campaign in Spring 2006 to support the official national launch of the Today Sponge, the firm says. The OTC contraceptive, which contains nonoxynol-9, is now available for sale through drugstore.com, the firm adds. The product is not fully distributed nationwide yet due to capacity constraints. Currently the product is available at Walgreens, Rite-Aid and CVS stores. FDA recently re-approved the contraceptive product in April, 10 years after American Home Products (now Wyeth) removed it from the market due to quality control concerns. The sponge became available online through the Allendale, N.J.-based firm's website in late August and began reaching drugstores in September (1"The Tan Sheet" April, 25, 2005, p. 9)...

You may also be interested in...



Spongeworthy: FDA Deems Today Sponge Contraceptive Safe For Use

The Today Sponge will be available directly to consumers in June from manufacturer Allendale Pharmaceuticals' 1website following FDA approval of the product April 21

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation

Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098903

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel